‘Conversation with the Candidate’ 2020 issue: Health care


WE’RE NOT DOING IT. ADAM: FEW ISSUES IN THISTION ARE
TOUCHING EVERY SINGLE VOTER, AS
HEALTH CARE. AND THE AUDIEN
CONVERSATIONS ASKED A LOT OF
QUESTIONS ABOUT THE TOPIC. FROM MEDICARE TO DRUG PRICES,
MENTAL HEALTH CARE TO MEDICAL
RESEARCH, MANY OF THE DEMOCRATIC
PHILOSOPHIES, BUT THERE ARE
DIFFERENCES WHEN IT COMES TO
>>MEDICARE NSIVE HEALTH CARE TO PEOPLE WITHOUT DEDUCTIBLES AND
AND IF YOU THINK THAT’S TOO GOOD
TO BE TRS AROUND T
WORL
NOW, ONE OF THE REASONS THAT WE
HAVE NOT YET DANADA AND OTHER COUNTRIES HAVE DONE IS
THE INCREDIBLE POWER OF THE
PHARMACEUTICAL INDUSTRY AND THE
INSURANCE COMPANIES. YOU DIDN’T ASK ME ABOUT THE COST
OF PRESCRIPTION DRUGS. WHY DO YOU T
MUCH FOR PRESCRIPTION DRUGS AS
DO THE PEOPLE OF ANY OTHER
COUN
BECAUSE LAST YEAR THE TOP 10
DRUG COMPANIES MADE $69 BILLION IN PROFIT AN
AMERICANS CAN’T EVEN AFFORD THE
PRESCRIPTION DRUGS THEIR DOCTORS
PRESCRIBE. THESE AR
THE INSURANCE COMPANIES HAVE RIP
PEOPLE, AND SO DO THE INSURANCE
COMPANIEBUT I THINK WHAT THE AME
PEOPLE UNDERSTAND IS THAT HEALTH
CARE IS ABLE TO GET THE PRESCRIPTION DRUGS THEY NEED
WITHOUT BEING RIPPED OFF. WE’RE GOING TO TAKE ON THE DRUG
COMPANIES AND WE’RE GOING TO
TAKE ON THE INSURANCE COMPANIES. AND HERE ON WMUR, YOU KNOW WHAT
YOU’RE GOING TO SEE? A LOT OF 30-SECOND ADS ATTACKING
BERNIE SANDERS AS A TERRIBLE
HUMAN BE
BECAUSE THESE GUYS ARE — THEY
LOVE THE STATUS QUO. CEO’S GET HUGE COMPENSATION
PACKAGES, THESE GUYS MAKE
BILLIONS. BUT THE TIME IS NOW TOSAY HEALTH
RIGHT, EVERYBODY SHOULD BE ABLE
TO GET THE HEALT
WITHOUT THOSE DEDUCTIBLES AND
WITHOUT THOSE COPAYMENTS.>>I BELIEVE THAT WE NEED A NEW
HEALTH CARE SYSTEM. HAD DIABETES, AND MY BROTHER
JOAQUIN AND I WATCHED AS WE GOT
OLDER AND SHE GOT OLDER, WEN GET
AND WORSE UNTIL, RIGHT BEFORE
SHE PASSED AWAY IN 1996, SHE H
TO HAVE ONE OF HER FEET AMPUTATED,
WHICH IS VERY COMMON FOR PEOPLE
WITH SEVERE
SHE HAD TYPE II DIABETES. THAT WHOLE TIME, THOUGH, SHE HAD
MEDICARE. I WANT TO STRENGTHEN MEDICARE
FOR THE PEOPLE WHO ARE ON
WHO HAVE IT, AND THEN MAKE SURE
THAT EVERYBODY CAN HAVE ACCESS
TO MEDICARE IF THEY WANT I
AS PART HINGS LIKE MAKE SURE THAT THE GOVERNMENT CAN
NEGOTIATE DRUG PRICES. AND THAT WE’RE ABLE TO LOWER
OF THA
HERE IN NEW HAMPSHIRE, FOR
INSTANCE, OR IN MY NECK OF THE
WOODS IN TEXAS — UP HERE
TEXAS THEY HAVE TO GO TO CANADA TO GET CHEAPER DRUGS
THEY GO TO MEXICO. THAT SHOULD NEVER BE THE CASE IN
THE UNITED STATES. AND I WILLTS,
ALL LEGISLATION TO MAKE SURE
THAT WE CAN BRING DOWN THAT
COST. EED TO
CHANGE OUR HEALTH CARE SYSTEM TO
ONE WHERE HEALTH CARE AND
MEDICATION IS AVAILABLE TO
EVERYBODY.>>DRUG PRICING IS ONE OF THTION
BECAUSE AT SOME LEVEL, DRUG
COMPANIES ARE COMING UP WITH
THINGS, AND THEY’RE GOING TO
CONTINUE TO COME UP WITH THINGS
THAT ARE GOING TO SAVE LIVES AND MAKE PEOPLE BE ABLE TO LIVE MUCH
MORE HEALTHY WHILE THEY’RE
AND I THINK IT WE SHOULD STA
BY SAYING PART OF THE GENIUS OF
AMERICA IS WE ARE GOING TO SOLVE
A LOT OF THINGS THAT WOULD HAVE KILLED US A GENERATION AGO. YOU THINK ABOUT BREAST CANCER. THAT USED TO BE A DEATH
SENTENCE. LEUKEMIA. NON-HODGKINS LYMPHOMA. THE AMERICAN MEDICAL RESEA
YOU KNOW, COHORT, IS DOING AND
HAS DONE INCREDIBLE THINGS FOR
US
AND THAT’S PART OF T
THE WAY IT WORKS — I DON’T KNOW HOW MUCH YOU GUYS KNOW ABOUT
THIS, BUT IF YOU GET A NEW DRUG
THAT’S PERMITTED BY THE FOOD AND
YOU GET A PATENT ON IT THAT ON
YOU CAN MAKE IT FOR SEVEN YEARS. AND YOU GET TO CHARGE WHATEVER
YOU WANT. WHICH, IF YOU HAVE A DRUG THAT’S
GONNA KEEP PEOPLE ALIVE, YOU CAN
CHARGE A LOT
WE ALL KNOW THAT. BUT AT THE END OF SEVEN YEARS,
THE PATENT’S SUPPOSED TO RUN
OU’S WHEN THE SYSTEM GET
REALLY SPOOKY, AND I’LL TELL YOU
WHY. THEY DO A BUNCH OF T
IN MY MIND, THE GOVERNMENT
SHOULD NEVER ALLOW THEM TO DO. THEY DO A BUNCH OF THINGS TO
EXTEND THAT PATENT FOR YEARS SO
THAT INSTEAD OF IT GOING FROM
BEING ON-PATENT TO BEING A
GENE
MAKE, THEY EXTEND IT IN A VARIETY OF WAYS, INC
THAT I CONSIDER
STRAIGHTFORWARDLY UNETHICAWHERE
WE HAVE THE PROBLEM, BECAUSE I
KNOW WE HAVE TO INCENT PEO

Add a Comment

Your email address will not be published. Required fields are marked *